Re: ZEN-3694 mCRPC Trial Status

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZEN-3694 mCRPC Trial Status

in response to

Re: ZEN-3694 mCRPC Trial Status

Toinv

posted on Oct 26, 2017 12:57PM

Toniv asked in his previous post "So what are the options for me to get money for my shares?" in regards to selling a "star" from the Star Factory. Great question for the AGM!

As for your inquiry of Q&A during the BIO Investor Forum last week.....these were short presentations that were not structured to allow for Q&A following the presentation. Short time slots of ~15 minutes, taken up entirely by the presentation. I think they encourage 1 on 1 meetings for follow up.